Relevance of ctdnalit-20261011-zeng2026-protocol-se-validation to "Which measured methylation workflow detects tumour-derived plasma DNA and, where separately supported, identifies tissue of origin?"
- Use case
- Select a plasma ctDNA methylation detection workflow
- Assessed by
- Zeng et al. 2026 SE 10% hold-out set: cancer vs healthy
- Relevance
- Proxy evidence
- Endpoint
- Cancer vs healthy ROC-AUC and sensitivity at 99% specificity (means over 10 fold models) for cfMeDIP-seq methylation, fragmentomic feature sets of the same reads and their combinations: se 10% hold-out set
A same-sample comparison of a measured methylation workflow (cfMeDIP-seq) with fragmentomic features and their combination, at a declared 99% specificity. Proxy rather than direct: the cohorts are clinically diagnosed and largely advanced cancers against healthy donors, the specificity is a fold-model threshold rather than a locked screening threshold, and the developer ran every arm.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
40 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations2 values
| A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Citation locations2 values
| Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison group zeng2026-cfmedip-feature-sets Context-only references | A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison group zeng2026-cfmedip-feature-sets Context-only references | Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison title cfMeDIP-seq methylation and fragmentomic feature sets on the same samples (Zeng et al. 2026) Context-only references | A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Comparison title cfMeDIP-seq methylation and fragmentomic feature sets on the same samples (Zeng et al. 2026) Context-only references | Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints3 values
| A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints3 values
| Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Cancer vs healthy ROC-AUC and sensitivity at 99% specificity (means over 10 fold models) for cfMeDIP-seq methylation, fragmentomic feature sets of the same reads and their combinations: se 10% hold-out set Context-only references | A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Cancer vs healthy ROC-AUC and sensitivity at 99% specificity (means over 10 fold models) for cfMeDIP-seq methylation, fragmentomic feature sets of the same reads and their combinations: se 10% hold-out set Context-only references | Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
2 source records and release history
- A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection · Original source · Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
- Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Original source · 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Technical metadata and extraction receipts
Stable ID: use-case-mapping-ctdna-lit-20261011-zeng2026-meth-se-validation
- field
- links:assessed_by:ctdnalit-20261011-zeng2026-protocol-se-validation
- value
- ctdnalit-20261011-zeng2026-protocol-se-validation
- relevance
- proxy
- endpoint
- Cancer vs healthy ROC-AUC and sensitivity at 99% specificity (means over 10 fold models) for cfMeDIP-seq methylation, fragmentomic feature sets of the same reads and their combinations: se 10% hold-out set
- rationale
- A same-sample comparison of a measured methylation workflow (cfMeDIP-seq) with fragmentomic features and their combination, at a declared 99% specificity. Proxy rather than direct: the cohorts are clinically diagnosed and largely advanced cancers against healthy donors, the specificity is a fold-model threshold rather than a locked screening threshold, and the developer ran every arm.
- constraints
- Inspect every linked evaluation's source locator and preserved limitations before citing a result.; Do not combine this mapping's evaluations with any other protocol's results; assays, cohorts and validation designs differ.; Fold-model means are not sample-level confidence intervals; spreads are across 10 fold models.
- limitations
- Developer study: the authors produced the cfMeDIP-seq cohorts and built and ran every classifier.; Clinically diagnosed cancers, many metastatic or advanced, against healthy donors; not an intended-use screening population.; Values are summaries over the 10 cross-validation fold models; the fold-level spread is reported, not a confidence interval over samples.; Fragmentomic features are computed from cfMeDIP-enriched (methylated) fragments, not from whole-genome sequencing.; Spread of sensitivity values: Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e.; A 10% hold-out of the same study (39 samples, 9 healthy), not an independent cohort.; The hold-out set has 9 healthy controls, so a 99% specificity threshold allows no false positive among them (counts from the source; the resolution is Rewire arithmetic).
- citation locators
- source id: ctdnalit-20261011-zeng2026-source-article; locator: Results P28-P33; Fig. 4 legend; Methods P59-P62; source id: ctdnalit-20261011-zeng2026-source-source-data-fig4; locator: Sheets Fig.4a-Fig.4h
- source locator
- ctdnalit-20261011-zeng2026-source-article: Results P28-P33; Fig. 4 legend; Methods P59-P62; ctdnalit-20261011-zeng2026-source-source-data-fig4: Sheets Fig.4a-Fig.4h
- revision
- 1
- reason
- Add the same-sample cfMeDIP-seq methylation and fragmentomic classifier comparison of Zeng et al. 2026 (Nature Cancer), retrieved 2026-10-11. Independently reviewed in docs/reviews/use-cases/plasma-ctdna-use-cases-2026-10-12.md.
- comparison group
- zeng2026-cfmedip-feature-sets
- comparison title
- cfMeDIP-seq methylation and fragmentomic feature sets on the same samples (Zeng et al. 2026)
- headline metric
- auroc
- stratum label
- SE 10% hold-out set
- stratum order
- 4
- review
- method: source-hash-verification; independent-cell-check; scope-review; reviewer: claude; reviewer note: Separate Claude review agent (reviewer-ctdna), independent of the extractor uc-ctdna; no human review claimed; date: 2026-10-12; note: Re-downloaded the pinned artifacts and matched their SHA-256; compared every value, s.d. column, sheet, row label and header with a separate stdlib OOXML reader written for this review (the extractor's script was not run) and read the sheet dump in full; cross-checked the values quoted in Results P29, P32 and P33 against the sheet.
- reviewed evaluations
- ctdnalit-20261011-zeng2026-eval-se-validation-end-motifs; ctdnalit-20261011-zeng2026-eval-se-validation-methylation; ctdnalit-20261011-zeng2026-eval-se-validation-motif-methylation-1pct
- pins
- record id: ctdnalit-20261011-zeng2026-eval-se-validation-end-motifs; fields: status; links; attributes.origin; attributes.comparison; sha256: 62dc072d6149b2549a936a7aea6294f0cfffbcf057c0fbdfeca67839e1a31e10; record id: ctdnalit-20261011-zeng2026-eval-se-validation-methylation; fields: status; links; attributes.origin; attributes.comparison; sha256: 8f78e31739a8eccf2f65ba0da608df2b8c019d6dfae060bbf6626aa35282a4ec; record id: ctdnalit-20261011-zeng2026-eval-se-validation-motif-methylation-1pct; fields: status; links; attributes.origin; attributes.comparison; sha256: 3bf6c7aa3b50a56f422fe39aca8ef3ffcda4fc432a29ea2f7b26785bfc253c28; record id: ctdnalit-20261011-zeng2026-protocol-se-validation; fields: status; name; description; facets; source_ids; links; attributes; sha256: 8397b39fea1e1680971f3cd3bb965ae6dc2f48db3e086e9a4bee3524bb322096; record id: ctdnalit-20261011-zeng2026-result-se-validation-end-motifs-auroc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8c40428d146a2bcc7af539bebbc082070460db02adb2d0e50954ccc2a834c343; record id: ctdnalit-20261011-zeng2026-result-se-validation-end-motifs-sensitivity-99spec; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 536680b1d8e5b6b850d2c05d157167659bf8d09e2c25b1f961f7735e0aa57277; record id: ctdnalit-20261011-zeng2026-result-se-validation-methylation-auroc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 359250a0ef7b5b6da0571121b3dbf15abeb97af4eef27cdabc4b2364f85b48f3; record id: ctdnalit-20261011-zeng2026-result-se-validation-methylation-sensitivity-99spec; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d021e9c851ff42999d254de5164fd6af88adca813191dc9b9520341baca905d0; record id: ctdnalit-20261011-zeng2026-result-se-validation-motif-methylation-1pct-auroc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: cc3c7344c698fcfb9bc2ecec9d6e77aadbe2afe54fbb5d935d7c24a52f493342; record id: ctdnalit-20261011-zeng2026-result-se-validation-motif-methylation-1pct-sensitivity-99spec; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: c7c52d6743b1f8c027841f4ba0c3d73406a4b485f9bb30f1b021510cb8cd17b6; record id: ctdnalit-20261011-zeng2026-source-article; fields: status; attributes.artifact_sha256; sha256: 14e562e77825d183e70cbfb33efc8db055781fca389a81fbd03555aad9c9c003; record id: ctdnalit-20261011-zeng2026-source-source-data-fig4; fields: status; attributes.artifact_sha256; sha256: 53d9d739aa6fbe6c6021403a20027a73229eaf176892d4e2b0625e426ab83e8f; record id: use-case-plasma-ctdna-methylation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 4d9542463e1400d5d9701c7f52859a23e4c78804cbda1477663445f945e22429